Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2024 financial results on Monday, February 10, 2025 after the financial markets close. The company will ...

Photo: FDA Fordian methods enabled more rational ... the controversy with tough pricing demands for new therapies for cystic fibrosis, leading to stand-offs lasting several years with payers ...

Choose from Fibrosis An stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. ... Photos Back Photos home Curated sets Signature collection ...

Children whose cystic fibrosis is caused by a rare gene variant are excluded from a new treatment which could potentially ...

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

West Virginia University microbiologists have identified an antibody that can kill one of the most drug-resistant bacteria.

A new report released by the Alberta Medical Association says the number of Albertans without primary care, combined with ...

Learn about cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs, and how to treat and live with this chronic disease. 12 min read What Is Cystic Fibrosis? Cystic ...